Health officials around the country resumed offering Johnson & Johnson ’s Covid-19 vaccine this weekend after getting a green light from federal regulators on Friday.
The U.S. Food and Drug Administration and U.S. Centers for Disease Control and Prevention lifted their recommendation to pause the shots after investigating reports of rare but potentially dangerous blood clotting in certain recipients. On Friday, FDA and CDC officials said inoculations could continue because their benefits outweigh their risks.
The FDA issued updated informational guides that inform vaccine recipients and doctors of the risk of blood-clotting that primarily has affected adult women under 50. The overall risk is about 1.9 cases per million people, though the risk is about 3.5 times higher for women ages 18 to 49, officials said.
The Indiana Department of Health said it began administering the J&J shot on Saturday to adults age 18 and up at a mass vaccination site at the Indianapolis Motor Speedway. The site administered 2,515 doses of the J&J vaccine on Saturday and an additional 1,325 doses through late afternoon on Sunday, said a spokesman for Indiana University Health, which is helping run the site.
Florida started offering the shots again on Sunday at federally supported vaccination sites in Tampa, Orlando, Jacksonville and Miami, said the state’s Division of Emergency Management.